Categories: BioTechDataDevelopmentDrugLearnLifeProductResearchTalent
Learning the Language of Life™
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.04.2024 | - | $1B | - |
Mentions in press and media 5
| Date | Title | Description |
| 25.04.2024 | Xaira Therapeutics: A Billion-Dollar Bet on AI Drug Discovery | In the fast-paced world of tech and biotech, Xaira Therapeutics emerges as a powerhouse with a massive $1 billion in funding. Led by CEO Marc Tessier-Lavigne, a former Stanford president and Genentech chief scientific officer, Xaira is read... |
| 25.04.2024 | Generative AI for Healthcare: Xaira Therapeutics Launches with $1 Billion Funding | Quincy Jon, Tech Times 25 April 2024, 09:04 am
ARCH Venture Partners and Foresite Labs, a Foresite Capital subsidiary, announced a revolutionary AI-driven drug discovery effort. With a $1 billion investment, they founded Xaira Therapeutics.... |
| 24.04.2024 | Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs | Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery.
On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of... |
| 24.04.2024 | Xaira Therapeutics Launches With Over USD1 Billion in Funding | Xaira Therapeutics, a San Francisco, CA-based integrated AI biotechnology company, launched with more than $1 Billion of committed capital.
Backers included ARCH Venture Partners and Foresite Capital, F-Prime, NEA, Sequoia Capital, Lux Capi... |
| - | Xaira Therapeutics | “Learning the Language of Life™” |
Reviews 0
